Coronary vasoactivity of four 7,13-bridged analogs of arachidonic acid.
Four newly synthesized 7,13-bridged arachidonic acid analogs which have been shown to exert 5-lipoxygenase inhibitory activity were studied in isolated perfused cat coronary arteries. The two dehydro analogs constricted and the two non-dehydro analogs dilated the coronary arteries. None antagonized LTD4 induced constriction. Thus there is no direct connection between lipoxygenase inhibition and leukotriene inhibition or vasoactivity.